All publications

Export 21 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is E  [Clear All Filters]
2018
Lodi S, Günthard HF, Dunn DT, Garcia F, Logan R, Jose S., Bucher HC, Scherrer AU, Schneider M-P, Egger M et al..  2018.  Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance.. AIDS. 32(3):327-335.
Stirrup OT, Dunn DT.  2018.  Estimation of delay to diagnosis and incidence in HIV using indirect evidence of infection dates.. BMC Med Res Methodol. 18(1):65.
2015
Mbisa JL, Fearnhill E, Dunn DT, Pillay D, Asboe D, Cane P A.  2015.  Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United Kingdom. Clin Infect Dis. 61:829-36.
2012
Castro H, Pillay D, Sabin CA, Dunn DT.  2012.  Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance. BMC Med Res Methodol. 12:30.
Bulteel N, Nelson M, Churchill D, Sabin CA.  2012.  The emergence of drug resistant HIV variants at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine within the UK CHIC cohort. 18th Annual Conference of the British HIV Association, 18-20 April 2012.
Hodcroft E, Fearnhill E, Phillips AN, Dunn DT, Pillay D, Hadfield J, Leigh Brown A, UK HIV Drug Resistance Database.  2012.  Estimating the heritability of viral determination of progression rate. 19th International HIV Dynamics & Evolution Conference, 25-28 April 2012.
Dolling D, Phillips AN, Delpech V, Pillay D, Cane P A, Crook A.M, Shepherd J., Fearnhill E, Hill T, Dunn DT.  2012.  Evaluating the extent of potential resistance to pre-exposure prophylaxis within the UK HIV-1-infectious population of men who have sex with men. HIV Med. 13:309-14.
2011
Wittkop L., Günthard HF, de Wolf F., Dunn DT, Cozzi-Lepri A, De Luca A., Kucherer C., Obel N., von Wyl V., Masquelier B. et al..  2011.  Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis. 11:363-71.
2010
Harrison LJ, Castro H, Cane P A, Pillay D, Booth C, Phillips AN, Geretti AM, Dunn DT.  2010.  The effect of transmitted HIV-1 drug resistance on pre-therapy viral load. AIDS. 24:1917-22.
Harrison LJ, Castro H, Cane P A, Pillay D, Booth C, Phillips AN, Geretti AM, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2010.  The effect of transmitted HIV-1 drug resistance on pre-therapy viral load. International HIV & Hepatitis Virus Drug Resistance Workshop & Curative Strategies, June 2010.
Fox J, Castro H, Kaye S, McClure M, Weber JN, Fidler S.  2010.  Epidemiology of non-B clade forms of HIV-1 in men who have sex with men in the UK. AIDS. 24:2397-401.
2009
Geretti AM, Harrison LJ, Green H, Sabin CA, Hill T, Fearnhill E, Pillay D, Dunn DT.  2009.  Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy. Clin Infect Dis. 48:1296-305.
Pond S.LKosakov, Posada D., Stawiski E., Chappey C., Poon A.F, Hughes GJ, Fearnhill E, Gravenor M.B, Leigh Brown A, Frost S.D.  2009.  An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1. PLoS Comput Biol. 5:e1000581.
2008
Geretti AM, Harrison LJ, Green H, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2008.  Effect of HIV-1 subtype on virological and immunological response to first-line HAART. 6th European HIV Drug Resistance Workshop, 26-28 March 2008.
Harrison LJ, Geretti AM, Green H, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2008.  Effect of HIV-1 subtype on virological and immunological response to first-line HAART. British HIV Association 14th Annual Conference, 23-25 April 2008.
2007
Nebbia G, Sabin CA, Dunn DT, Geretti AM.  2007.  Emergence of the H208Y mutation in the reverse transcriptase (RT) of HIV-1 in association with nucleoside RT inhibitor therapy. J Antimicrob Chemother. 59:1013-6.
Fox J, Dudaz A, Green H, Dunn DT, Kaye S, McClure M, Fidler S, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2007.  Epidemiology of non-B clade forms of HIV-1 in MSM in the UK. 13th Annual Conference of the British HIV Association, 25-28 April 2007.
UK Collaborative Group on HIV Drug Resistance, UK Collaborative HIV Cohort Study(UK CHIC), UK Register of HIV Seroconverters.  2007.  Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom. AIDS. 21:1035-9.
2005
Pillay D, Green H, Matthias R, Dunn DT, Phillips AN, Sabin CA, Evans B..  2005.  Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom. J Infect Dis. 192:967-73.